About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials in Arizona | 544 Studies

Clinical Trials Lung CancerArizona

Lung Cancer Clinical Trials in Arizona

Find 544 clinical trials for lung cancer near Arizona. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 521-540 of 544 trials

CompletedPaclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00096226·Phoenix, Arizona and 21 others TerminatedBasket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsThis is an open-label, multicenter, multinational, Phase 2 basket study exploring the efficacy and safety of neratinib as monotherapy or in combination with other therapies in…NCT01953926·Birmingham, Alabama and 59 others

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedBIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)This randomized, double-blind, multi-center Phase IIb/III trial will be performed in patients with NSCLC who have received previous treatment with at least one but not more than…NCT00656136·Kingman, Arizona and 89 others

RecruitingStudy of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other CancersThis is a phase 1/2, multicenter, open-label study.NCT05098132·Tucson, Arizona and 46 others

CompletedA First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced MalignanciesThe goal of this Open-Label Study is to evaluate the safety and tolerability of PRTH-101 alone or in combination with pembrolizumab in adults with advance or metastatic solid…NCT05753722·Scottsdale, Arizona and 10 others

TerminatedA Dose Escalation Trial of PR610 Treating Patients With Solid TumorsThe purpose of this study is to determine the Maximum Tolerated Dose and the Dose-Limiting Toxicity of the drug to further evaluate safety and antitumor activity.NCT01631279·Scottsdale, Arizona and 5 others

CompletedKEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C)The purpose of this study is to assess the efficacy and safety of pembrolizumab (MK-3475) in combination with boserolimab (MK-5890), MK-4830, MK-0482 in participants with advanced…NCT04165096·Gilbert, Arizona and 38 others

CompletedA Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung CancerThe purpose of this study is to determine if MEDI4736 will be adequately tolerated in combination with tremelimumab in subjects with advanced non-small cell lung cancer (NSCLC).NCT02000947·Birmingham, Alabama and 68 others

RecruitingFirst-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid TumorsA multicenter, single-arm, first-in-human study to investigate the safety, pharmacokinetics, and preliminary antitumor activity of PLX-61639 in participants with locally advanced…NCT07284186·Scottsdale, Arizona and 9 others

Completed⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's LymphomaTo determine the safety and feasibility of 89Zr-Df-IAB22M2C as an immunoPET tracer; determine the best time window and protein dose for imaging; determine the pharmacokinetic (PK)…NCT03107663·Scottsdale, Arizona and 2 others

CompletedPlatinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by SurgeryThis randomized phase II trial studies how well platinum doublet chemotherapy and proton beam radiation therapy work in treating patients with stage II-III non-small cell lung…NCT03132532·Scottsdale, Arizona and 1 other

Active not recruitingA Phase 1 Clinical Study of NXP900 in Subjects With Advanced CancersThis is a multi-center, first-in-human, open label, dose escalation (Part A) and expansion (Part B) Phase 1 study in subjects with advanced solid tumors and in subjects with solid…NCT05873686·Phoenix, Arizona and 14 others

CompletedIntravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast CancerRATIONALE: Interleukin-4 PE38KDEL cytotoxin may be able to deliver cancer-killing substances directly to solid tumor cells.NCT00039052·Tucson, Arizona and 1 other

TerminatedA Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) PopulationThis is a Phase II, randomized, open-label, multi-center study in advanced (Stage IVA and IVB subjects per the International Association for the Study of Lung Cancer (IASLC) 2009…NCT01313663·Tucson, Arizona and 24 others

CompletedInositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial DysplasiaThis randomized phase II trial is studying inositol to see how well it works compared with a placebo in preventing lung cancer in current or former smokers with bronchial…NCT00783705·Scottsdale, Arizona and 3 others

Active not recruitingBasket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsThis trial studies how well tucatinib works for solid tumors that make either more HER2 or a different type of HER2 than usual (HER2 alterations) The solid tumors studied in this…NCT04579380·Phoenix, Arizona and 107 others

CompletedIressa Expanded Access Program (EAP)A program for patients with non small cell lung cancer who may benefit from Iressa, but cannot enter another clinical trial due to them not being eligible, or for whom no trials…NCT00034879·Alabaster, Alabama and 625 others

TerminatedDexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung CancerThis study will look at how dexamethasone and placebo influence radiation fatigue, quality of life and number of treatment days missed during radiation therapy or radiation…NCT02410382·Tucson, Arizona

TerminatedSafety Study of SEA-CD40 in Cancer PatientsThis study is being done to find out if SEA-CD40 is safe and effective when given alone, in combination with pembrolizumab, and in combination with pembrolizumab, gemcitabine, and…NCT02376699·Birmingham, Alabama and 18 others

TerminatedStudy of Itacitinib in Combination With Docetaxel in Subjects With Non-Small Cell Lung CancerThe primary objectives of this study were to evaluate the safety and tolerability of itacitinib in combination with docetaxel and to select doses for further evaluation (Part 1…NCT02257619·Hot Springs, Arizona and 15 others

PreviousPage 27 of 28Next

Other Conditions in Arizona

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma